Autonomous University of Barcelona:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Autonomous University of Barcelona - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9351
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Autonomous University of Barcelona (UAB) is a public university that offers education, research and knowledge transfer services. The university provides undergraduate, post graduate, masters, doctorates, and foreign undergraduate programs. It offers educational programs in the areas of arts and science; humanities, social sciences and law, philosophy, economics and medicine, speech therapy, computational mathematics and data analytics, among others. The university also conducts research activities in the fields of animal and food science; medicine; pharmacology, therapeutics and toxicology; psychiatry and legal medicine, surgery, computer science, animal health and anatomy; experimental and technological sciences, social sciences, and others. UAB is headquartered in Barcelona, Spain.

Autonomous University of Barcelona – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autonomous University of Barcelona, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
R-Tech Ueno Plans to Enter into Research Agreement with UAB and VHIR 10
Licensing Agreements 11
Kogenix Therapeutics Enters into Licensing Agreement with University of Barcelona and Vall d’Hebron Research 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
Autonomous University of Barcelona – Key Competitors 13
Autonomous University of Barcelona – Key Employees 14
Autonomous University of Barcelona – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Feb 20, 2018: RAC1 protein could be a new therapeutic target to fight neurodegeneration in Parkinson’s disease 16
Product News 18
Jun 07, 2018: First photoactive drug to fight Parkinson’s disease 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Key Facts 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autonomous University of Barcelona, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autonomous University of Barcelona, Deals By Therapy Area, 2012 to YTD 2018 8
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
R-Tech Ueno Plans to Enter into Research Agreement with UAB and VHIR 10
Kogenix Therapeutics Enters into Licensing Agreement with University of Barcelona and Vall d'Hebron Research 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
Autonomous University of Barcelona, Key Competitors 13
Autonomous University of Barcelona, Key Employees 14
Autonomous University of Barcelona, Subsidiaries 15

List of Figures
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autonomous University of Barcelona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Autonomous University of Barcelona:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Redx Pharma Plc (REDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza …
  • Phoenix Children’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • Akebia Therapeutics Inc (AKBA):企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • BioView Ltd (BIOV):医療機器:M&Aディール及び事業提携情報
    Summary BioView Ltd (BioView) develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright-field microscopes fitted with hig …
  • CG Power and Industrial Solutions Ltd (CGPOWER)-エネルギー分野:企業M&A・提携分析
    Summary CG Power and Industrial Solutions Ltd (CG), formerly Crompton Greaves Limited provides solutions for the management and application of electrical energy. It carries out the design, manufacture and marketing of electrical products and services related to utilities, power generation and indust …
  • Buffalo Rock Company:企業の戦略・SWOT・財務情報
    Buffalo Rock Company - Strategy, SWOT and Corporate Finance Report Summary Buffalo Rock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NovoCure Ltd (NVCR):企業の製品パイプライン分析2018
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Boone Electric Cooperative:企業の戦略的SWOT分析
    Boone Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Alafair Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Alafair Biosciences Inc (Alafair Biosciences) is a medical device company that develops and commercialize surgical products for soft tissue repair and protection applications. The company develops products based on a non-cell adhesive hydrogel technology to protect and manage advanced wound …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Investec Private Bank (South Africa):企業の戦略・SWOT・財務情報
    Investec Private Bank (South Africa) - Strategy, SWOT and Corporate Finance Report Summary Investec Private Bank (South Africa) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • EnServe Group Limited:企業のM&A・事業提携・投資動向
    EnServe Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnServe Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • British Polythene Industries Plc
    British Polythene Industries Plc - Strategy, SWOT and Corporate Finance Report Summary British Polythene Industries Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • KACO new energy GmbH:企業の戦略的SWOT分析
    KACO new energy GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Avedro Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • Multiplan Empreendimentos Imobiliarios SA:企業の戦略・SWOT・財務情報
    Multiplan Empreendimentos Imobiliarios SA - Strategy, SWOT and Corporate Finance Report Summary Multiplan Empreendimentos Imobiliarios SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Huhtamaki Oyj:企業の戦略・SWOT・財務情報
    Huhtamaki Oyj - Strategy, SWOT and Corporate Finance Report Summary Huhtamaki Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Taisei Corporation:企業の戦略・SWOT・財務分析
    Taisei Corporation - Strategy, SWOT and Corporate Finance Report Summary Taisei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ceres Power Holdings Plc (CWR):電力:M&Aディール及び事業提携情報
    Summary Ceres Power Holdings Plc (Ceres Power) is an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power and heat …
  • Lindsey Manufacturing Co:企業の戦略的SWOT分析
    Lindsey Manufacturing Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆